相关实验视频
Updated: Jun 11, 2025

07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
3.9K
超越指导方针:对患有高甘油三血症的儿科患者管理的前景
Charles A Gagnon1, Ambika P Ashraf2
1University of Alabama at Birmingham Marnix E. Heersink School of Medicine, Birmingham, AL, USA.
Current atherosclerosis reports
|September 30, 2024
概括
年轻人患高甘油三血症 (HTG) 需要更好的分类和管理. 新兴疗法在降低心血管和胰腺炎风险方面表现有前途,需要进一步研究.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 心血管风险管理心血管风险管理
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 年轻人患高甘油三血症 (HTG) 是一个越来越令人担忧的问题,对长期心血管健康有影响.
- 目前对儿科甘油三水平 (TG) 的分类和管理策略已经确定了差距.
- 了解HTG的病理生理学,包括遗传和二次因素,对于有效治疗至关重要.
研究的目的:
- 在青少年中全面审查高甘油三血症 (HTG).
- 为了确定三甘 (TG) 水平分类和当前管理策略中的差距.
- 探索用于儿童群体TG降低的新疗法.
主要方法:
- 对当前关于儿科高血糖三血症的研究进行文献综述.
- 对TG级别分类和管理的现有指导方针进行分析.
- 探索新兴的药理目标和TG降低的治疗方法.
主要成果:
- 非禁食的甘油三 (TG) 水平是年轻人心血管风险的重要指标.
- 针对脂蛋白脂酶,apoC3和ANGPTL3的新兴疗法显示出降低TG的潜力.
- 需要针对年轻人量身定制的具体管理方法,以及对新疗法的进一步研究.
结论:
- 对于青少年中HTG的精细分类和管理策略非常需要.
- 新型治疗药物为降低TG水平和相关风险提供了有希望的途径.
- 进一步的研究对于确定新型TG降低治疗在儿科患者群体中的疗效和安全性至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
581
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
581
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Acute Pancreatitis II: Clinical Manifestations and Management
95
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
95
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Hypoglycemia and Glucagon
206
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
206

